treating spinal disorders

Korean chipmakers Samsung strives to prevent musculoskeletal disorders in the workplace

Samsung Electronics Co., the world’s largest memory chipmaker, is striving to prevent musculoskeletal disorders (MSDs) in its workplace to imp...

Retail CU to sell souvenir snack set for foreign tourists

South Korean convenience store chain CU next month will launch a souvenir snack set for foreign tourists.This will be the first product of its kind ...

Bio & Pharma Red ginseng proven to treat drug addiction: Research

It has been revealed that red ginseng significantly improves drug addiction and withdrawal symptoms caused by substance abuse. The research results ...

Bio & Pharma S.Korea's Boryung gets gov’t OK for diabetes drug Trubuddy

South Korea’s Boryung Corp. on Tuesday said it received approval from the Ministry of Food and Drug Safety for its new compound diabetes drug ...

Bio & Pharma Handok to import treatment for rare autoimmune disorder

South Korean pharmaceutical company Handok Inc. on Wednesday said it signed a deal with Dutch immunology specialist Argenx to sell the latter's Vyvg...

Bio & Pharma HLB signs with Japan's OSCL for exclusive supply of C-Trelin ingredient

South Korea's pharmaceutical company HLB Therapeutics Co. announced on Thursday that it has entered into a business agreement with Japan's Osaka Syn...

Beauty & Cosmetics Amorepacific gets certification for memory-enhancing ingredients

South Korea's Amorepacific Corp. announced on Thursday that it has received New Excellent Technology (NET) certification from the Ministry of Agricu...

Bio & Pharma S.Korea's Qurient, US National Cancer Institute to develop anti-cancer drug

South Korea's Qurient Co. announced on Monday that it signed a research and development agreement with the US government agency National Cancer Inst...

Bio & Pharma S.Korea's CGBio gets FDA approval for spinal implant

CGBio, a South Korean bio-regenerative medical company, announced on Monday that its "Advanced LumFix spinal fixation system," an implant and surgic...

Bio & Pharma Verismo's CAR-T therapy designated fast-track status by FDA

Verismo Therapeutics, a US affiliate of South Korean pharmaceutical firm HLB Co., has received fast-track designation from the US Food and Drug Admi...

Bio & Pharma GC Biopharma introduces candidates for treating blood coagulation disease

South Korea's GC Biopharma Corp. announced on Tuesday that it had entered into an agreement to transfer assets with Catalyst Biosciences, a US-based...

Bio & Pharma Hanall Biopharma invests in Interon Labs for brain disease treatments

South Korean pharmaceuticals firm Hanall Biopharma Co. is investing in Interon Laboratories, a US biotech firm that finds and develops treatments fo...

Regulations Korea may fine Aramco-backed Hyundai Oilbank $119 mn over wastewater

South Korea is set to impose a fine of 150.9 billion won ($118.9 million) on Hyundai Oilbank Co., a local refiner backed by Saudi Aramco, for allege...

Bio & Pharma Mezzion Pharma to try again for US FDA approval of drug

South Korea's Mezzion Pharma will seek to get the oral medicine Udenafil to treat side effects from heart surgery, planning to clinical trials in th...

Food & Beverage Korean snack shares surge, Beijing halts baked goods imports from Taiwan

Shares of South Korean confectionery and packaged snack makers skyrocketed after the Chinese government announced its decision to temporarily halt t...

Pharmaceuticals SK Biopharm aims to make it to global top 10 healthcare firms by 2030

South Korea’s SK Biopharmaceuticals Co. said on Friday it aspires to become one of the world’s top 10 healthcare companies by 2030 with ...